Cleared Traditional

K211952 - BTI Interna Narrow/Plus Dental Implant ...

K211952 is an FDA 510(k) clearance for BTI Interna Narrow/Plus Dental Implant ..., manufactured by B.T.I. Biotechnology Institute, Sl.. The device is a Class 2 Dental device with product code DZE cleared through the Traditional 510(k) pathway after a 393-day FDA review.

K211952 · B.T.I. Biotechnology Institute, Sl. · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2022
Decision
393d
Days
Class 2
Risk

K211952 is an FDA 510(k) clearance for the BTI Interna Narrow/Plus Dental Implant System UnicCa. Classified as Implant, Endosseous, Root-form (product code DZE), Class II - Special Controls.

Submitted by B.T.I. Biotechnology Institute, Sl. (Minano, ES). The FDA issued a Cleared decision on July 21, 2022 after a review of 393 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3640 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all B.T.I. Biotechnology Institute, Sl. devices

FDA 510(k) Submission Details - K211952

510(k) Number K211952 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 23, 2021
Decision Date July 21, 2022
Days to Decision 393 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
266d slower than avg
Panel avg: 127d · This submission: 393d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DZE Device Classification - Class 2, Special Controls

Product Code DZE Implant, Endosseous, Root-form
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - DZE Implant, Endosseous, Root-form

All 758
Devices cleared under the same product code (DZE) and FDA review panel - the closest regulatory comparables to K211952.
TSX Implants
K220978 · Biomet 3i, LLC · Sep 2022
Neodent Implant System - GM Narrow Implant System
K220251 · Jjgc Industria E Comercio DE Materiais Dentarios S.A. · Sep 2022
BLT Dental Implant System
K212364 · Bio Concept Co., Ltd. · Aug 2022
Tatum Surgical Dental Implant System
K213576 · Suncoast Dental, Inc. Dba Tatum Surgical · Jul 2022
Kontact Dental Implant System
K213997 · Biotech Dental, Sas · Jul 2022
SNUCONE Bone Level Implant System
K210354 · Snucone Co., Ltd. · Jul 2022